IL6 and Parkinson disease: Recent research by Zhang et al., showed that silencing of lncRNA AL049437 had reduced TNF-α, iL-6, and ROS production in MPP+ induced PD model, which significantly reduced the neuroinflammation and oxidative stress [84].